Company Profiles

driven by the PitchBook Platform

ADial Pharmaceuticals

ADial Pharmaceuticals
2007 FOUNDED
IPO REG STATUS
1-10 EMPLOYEES
IPO LATEST DEAL TYPE (Announced)
$14M LATEST DEAL AMOUNT
$20.8M TOTAL AMOUNT RAISED
Description

Developer of prescription medications designed to treat addictions and related disorders. The company's prescription medications offers advanced compound AD04 specifically targets alcohol use disorder and offers a simple blood test which can identify those patients who respond to treatment with AD04, enabling medical professionals to treat addiction diseases and disorders, including alcohol and drug addictions as well as for behaviors such as those related to obesity and eating disorders.

Ownership Status
In IPO Registration
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Drug Delivery
Primary Office
204 East High Street
Suite 100
Charlottesville, VA 22902
United States

+1 (434) 422-9800
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ADial Pharmaceuticals’s full profile, request a free trial.

ADial Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. IPO 07-Sep-2017 $14M $20.8M 000.00 Announced Clinical Trials - Phase 3
4. Angel (individual) 30-Aug-2017 0000 00.000 Completed Generating Revenue
3. Corporate 00.000 Completed Generating Revenue
2. Angel (individual) 02-Oct-2013 $2.63M $6.73M Completed Generating Revenue
1. Angel (individual) 16-Mar-2011 $4.1M $4.1M Completed Startup
To view this company’s complete deal history including valuation and funding request access »

ADial Pharmaceuticals Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Lindéngruppen Corporation Minority 000 0000 000000 0

ADial Pharmaceuticals Executive Team (3)

Name Title Board
Seat
Contact
Info
William Stilley III President, Chief Executive Officer and Board Member
Bankole Johnson Ph.D Co-Founder, Chairman and President
John Riccardi Chief Financial Officer

ADial Pharmaceuticals Board Members (10)

Name Representing Role Since Contact
Info
Bankole Johnson Ph.D ADial Pharmaceuticals Co-Founder, Chairman and President 000 0000
James Newman Jr. ADial Pharmaceuticals Board Member 000 0000
J. Kermit Anderson ADial Pharmaceuticals Board Member 000 0000
Joacim Björk Lindéngruppen Board Member 000 0000
Leonard Meyer Jr. ADial Pharmaceuticals Board Member 000 0000

1 Former Board Members

You’re viewing 5 of 10 board members. Get the full list »